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Abstract
To examine the relationship between vascular health, including flow-mediated dilation (FMD),
intima medial thickness (IMT), and neurocognitive performance in a sample of 124 sedentary,
middle-aged adults with high blood pressure (SBP 130–159 mmHg or DBP 85–99 mmHg) who
were overweight or obese (body mass index 25.0 – 39.99 kgs/m2). Patients completed a
neuropsychological test battery including measures of Executive Function and Psychomotor
Speed, along with measures of IMT and FMD. Hierarchical multiple regression analyses were
used to investigate the association between vascular measures and neurocognitive performance
after controlling for demographic factors and cerebrovascular risk factors. Higher levels of FMD
predicted better Executive Function (b = 0.90, P = .045). Greater IMT tended to be associated with
slower Psychomotor Speed (b = −0.82, P = .084), with the effect attenuated after controlling for
FMD. Impaired FMD is associated with worse neurocognitive functioning among overweight
adults with high blood pressure.
Introduction
Cerebrovascular disease is a major source of disability in the United States {Duron, 2008
6661 /id} and is associated with an increased risk of stroke {Lorenz, 2007 6697 /id}. It is
well-known that the presence of cerebrovascular risk factors (CVRF), such as hypertension,
hypercholesterolemia, diabetes, and tobacco use, are associated with microvascular ischemic
brain changes {Jeerakathil, 2004 11 /id}, and previous evidence has shown that the presence
of carotid plaque, atherosclerosis in the Circle of Willis, and intracranial stenosis are
associated with similar brain changes {Uehara, 1999 45 /id}. Additionally, increasing
evidence indicates that subtle vascular disease detected by peripheral measures may be
associated with important changes in brain vasculature prior to any clinical event (e.g.,
stroke) and that the underlying relationship between vascular health and cerebrovascular
damage may be continuous {Smith, 2007 6698 /id}.
Recent studies have shown that subclinical vascular disease is associated with poorer
neurocognitive functioning on tests of frontal-subcortical function (i.e., executive function)
{Cohen, 2009 6699 /id} as well as greater white matter hyperintensity burden {Hoth, 2007
20 /id}. We have previously reported that the relationship between CVRF, intima medial
thickness (IMT), and neurocognitive functioning may be mediated by endothelial
dysfunction, determined by impaired flow-mediation dilation (FMD) of the brachial artery,
among adults with major depressive disorder {Smith, 2007 6698 /id}. However, the
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relationship of FMD, IMT, and neurocognition has not been examined among individuals
with high blood pressure, a group at significantly elevated risk for neurocognitive
dysfunction. We therefore examined these relationships among 124 overweight or obese
adults with high blood pressure participating in the Exercise and Nutrition interventions for
CardiOvasculaR hEalth (ENCORE) study, the primary cardiovascular results {Blumenthal,
2010 6665 /id} and resulting neurocognitive changes recently have been reported {Smith,
2010 6737 /id}. Participants in the current study represent a subset of individuals who were
enrolled in ENCORE and who had complete neurocognitive test data. The present sample
was selected because individuals were overweight and had high blood pressure, both of
which are known to be associated with vascular disease {Al, 2001 6739 /id;Vanhoutte, 1996
6740 /id} and neurocognitive dysfunction {Elias, 2003 37 /id;Wolf, 2007 6685 /id}.
Methods
As detailed elsewhere, the ENCORE study was designed to examine the effects of exercise
and dietary modification on blood pressure and hemodynamic function {Blumenthal, 2010
6665 /id}. Inclusion criteria included blood pressure pre-hypertension or stage 1
hypertension (SBP 130–159 mmHg or DBP 85–99 mmHg), ≥ 35 years of age, BMI between
25.0 – 39.99 kgs/m2, and sedentary lifestyle. Exclusion criteria included a history of
cardiovascular disease or other significant medical co-morbidities that would limit the
individual’s ability to participate fully in the intervention and medications, including those
for weight loss, hypertension, insulin, and certain psychotropic medications. Participants
taking anti-depressants (N = 10) and/or psychostimulant medications (N =1) were included
in our analyses, although results were unchanged when these participants were eliminated.
Participants with a history of stroke, congestive heart failure, cardiovascular events (e.g.
myocardial infarction), peripheral vascular disease, diabetes, and cancer diagnosis in the
past two years were also excluded.
Neurocognitive Testing
Participants completed a neuropsychological test battery in order to assess performance in
the domains of Executive Function and Psychomotor Speed. Neurocognitive tests were
selected for the availability of multiple test versions, well-established psychometric
properties, and accepted clinical utility. We selected a range of test instruments in order to
provide a comprehensive assessment of Executive Function and Psychomotor Speed, which
are multifaceted neurocognitive processes. Accordingly, our test battery included measures
of information processing speed efficiency, sustained attention / vigilance, set-shifting
ability, learning efficiency, and verbal fluency, which are all various facets of Executive
Function and/or Psychomotor Speed.
Executive Function subtests included the Trail Making Test (B-A) {Reitan, 1979 391 /id},
the Stroop Test (Word, Color, and Color-Word sections) {Stroop, 1935 392 /id}, the Verbal
Paired Associates test {Wechsler, 1987 22 /id}, the Controlled Oral Word Association Test
(COWAT) {Wechsler D., 1956 395 /id}, the Digit Span test {Wechsler, 1987 22 /id}, and
the Verbal Fluency Test (Animal Naming) {Lezak, 1995 398 /id}. Psychomotor Speed
subtests included the Ruff 2 & 7 Test {Ruff R.M., 1992 23 /id}, and the Digit Symbol
Substitution Test {Wechsler, 1997 6199 /id}. In addition, both the Stroop Test and the
COWAT also loaded on our Psychomotor Speed variable. Details regarding the
administration and scoring of these tests are provided elsewhere {Smith, 2010 6737 /id}.
Blood Pressure and Medical Screening Information
Clinic blood pressure (BP) was measured using a standardized cuff size, position,
environment, and time of day. After five minutes of quiet rest, four seated BP readings were
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obtained using a standard mercury sphygmomanometer and stethoscope, each two minutes
apart for four screening sessions conducted over a 3–4 week period. Additional medical
history information was obtained from a standard medical screening examination.
Cerebrovascular risk was estimated using the Framingham Stroke Risk Profile (FSRP),
which is a risk assessment tool used to assess the 10-year incidence of stroke {D’Agostino,
1994 2972 /id} and was determined at the time of a baseline physical examination. Risk
factors used to assess stroke risk include SBP, diabetes mellitus, cigarette smoking,
cardiovascular disease, and atrial fibrillation. Because age served as a covariate in our final
analyses, it was not included in calculating FSRP scores. No participants reported a prior
history of stroke. High-density lipoprotein (HDL) and low-density lipoprotein (LDL)
cholesterol were measured enzymatically (LabCorp, Research Triangle Park, NC). HDL
cholesterol was estimated by assay of the supernatant remaining after precipitation of serum
LDL with dextran sulfate plus magnesium chloride. Participants fasted for 12 hours before
this assessment.
Measures of Vascular Health
Carotid artery IMT was measured using a high-resolution B-mode ultrasound vascular
imaging system (Acuson Aspen, Mountain View, CA) with a 10-Mhz linear array
transducer. Ultrasound examinations of the far wall of the left and right common carotid
arteries (CCAs) were used to acquire longitudinal images spanning 2 cm proximal to the
carotid bulb. IMT of the far wall of the left and right CCAs was measured over a 1-cm
segment using edge detection software (Carotid Analyzer 5.0.5, Medical Imaging
Applications LLC, Iowa City, IA). Far wall measurements only were used as near wall
measurements have been shown to have limited reliability.
Flow mediated dilation (FMD) and nitroglycerin mediated dilation (GTN-D) of the brachial
artery were assessed in the morning, after overnight fasting. Longitudinal B-mode
ultrasound images of the brachial artery, 4 to 6 cm proximal to the antecubital crease, were
obtained using an ultrasound platform (Aspen, Mountain View, CA) with a 10-MHz linear
array transducer. Images were obtained under the following conditions: a) after 10 minutes
of supine relaxation; b) during reactive hyperemia, induced after inflation for 5 minutes to
suprasystolic pressure (200 mm Hg) of a pneumatic occlusion cuff placed around the
forearm; c) after an additional 10 minutes relaxation period in the supine position; and d)
after the administration of 400 μg sublingual glyceryl trinitrate (GTN). End-diastolic images
were stored to a magnetic-optical disk and arterial diameters were measured as the distance
between the proximal and distal arterial wall intima media interfaces, using PC-based
software (Brachial Analyzer Version 4.0, Medical Imaging Applications LLC, Iowa City,
IA). Peak hyperemic flow was assessed by Doppler velocity measurement during the first 10
seconds post deflation of the occlusion cuff, and hyperemic flow response was defined as
percent change in flow relative to resting baseline. Peak FMD response was assessed from
10 to 120 seconds post deflation of the cuff, with peak arterial diameter quantified using
polynomial curve fitting. FMD was defined as the maximum percent change in arterial
diameter relative to resting baseline. GTN-D was defined as peak percent change in arterial
diameter assessed 3 to 5 minutes after the administration of GTN. FMD provides a putative
measure of endothelial function {Celermajer, 1992 6738 /id}, whereas GTN-D is interpreted
as measuring a more general vascular response.
Data Reduction and Analysis
To minimize the number of statistical tests in the present analysis, we used principle axis
factor analysis to combine information from the 10 individual neuropsychological tests into
three cognitive domain scores. A Scree test was used to determine the total number of
factors retained for analysis. A minimum loading of 0.40 was required and Promax rotation
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was used. We selected a Promax rotation, an oblique factor rotation method, in order to
account for the interrelationships between our measures of executive function and
processing speed. Based on these results, we created unit-weighted composite scores by
standardizing the individual neuropsychological test scores and then summing all subtests
relevant to a given domain. These composites were then used as the criterion variable in the
regression models described below.
Separate hierarchical multiple regression analyses were conducted for each cognitive
domain to determine if vascular functioning was associated with neuropsychological
performance independently background characteristics and CVRF. For each model, a
hierarchical approach was used in which variables were entered in blocks: 1) background
characteristics (age and years of education and baseline arterial diameter (FMD analyses
only)) and 2) CVRF (FSRP, lipids, and BMI). After these blocks were entered, we entered
IMT, GTN, and FMD alone to examine the contribution of each variable in the presence of
the first two blocks. As a final step, IMT and FMD were entered together in addition to the
first two blocks. We also conducted two exploratory analyses, as requested by an
anonymous reviewer. First, we examined which individual neuropsychological measures
were most strongly associated with FMD after controlling for background characteristics,
CVRF, and IMT. Second, we examined the pattern of findings when chronological age was
entered in the last step of our hierarchical regression model.
Model assumptions of additivity, linearity, and distribution of residuals were evaluated and
found to be adequate before analysis. Regression coefficients were scaled using the
interquartile range of the predictor variable. This scaling allows the coefficient to be
interpreted as comparing a “typical” person in the middle of the upper half of the predictor




Participants were generally middle-aged, college-educated, hypertensive, and obese. Nearly
two-thirds of the sample was female (64%) and 59% were Caucasian (Table 1). Framingham
Stroke Risk Profile scores ranged from 2 to 16 (median = 5). Examination of vascular health
indices showed that the vascular health in our sample was relatively lower than levels
reported from other population-based studies {Stein, 2008 6742 /id}. Neurocognitive
performance levels in our study were generally placed within the average range (i.e. 25th–
75th percentile) when compared with age- and demographically-adjusted normative values
{Heaton, 2004 6741 /id}.
Neurocognitive Function
Factor analytic results revealed two underlying neurocognitive factors, which we labeled
Psychomotor Speed and Executive Function (Table 2). Psychomotor Speed included the
Stroop Word, Color, and Color-Word sections, COWAT, Digit Symbol Substitution Test,
and the Ruff 2 & 7 Test. The second factor, which we labeled Executive Function, included
the Stoop Word and Color-Word sections, Trail Making Test B – A, Verbal Paired
Associates, COWAT, Animals, and the Digit Span. Our Psychomotor Speed and Executive
Function factors were strongly correlated (r = .80, P < .001).
Psychomotor Speed—Results from our hierarchical regression analyses of Psychomotor
Speed show that both age and education level were significantly associated with
Psychomotor Speed and these associations were only modestly attenuated with adjustment
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for other cerebrovascular risk factors and vascular functioning (Table 3). Cerebrovascular
risk factors were not associated with Psychomotor Speed when added to our model
(F(4,113) = 0.35, P = .842); neither LDL-C (b = −0.20, P = .609), HDL-C (b = −0.33, P = .
487), FSRP (b = 0.29, P = .388), nor BMI (b = −0.25, P = .666) were associated with
Psychomotor Speed. We noted a trend for IMT to be associated with Psychomotor Speed
when added after cerebrovascular risk factors (F(1,97) = 2.96, b = −0.82, P = .084), with
higher levels of IMT tending to predict poorer Psychomotor Speed performance. However,
FMD failed to predict better Psychomotor Speed performance (F(1,93) = 2.39, b = 0.72, P
= .126), even after controlling for IMT in the final model step (F(1,86) = 1.28, b = 0.54, P
= .261). Similarly, IMT was no longer a significant predictor of Psychomotor Speed once
FMD was included in our final model step (b = −0.78, P = .127).
In exploratory analyses, we found that the Stroop Word (b = 0.25, P = .014) and Stroop
Color-Word (b = 0.19, P = .058) tests were the most strongly related to FMD, whereas the
COWAT (b = 0.10, P = .328), Stroop Color (b = 0.01, P = .901), Ruff 2 & 7 Test (b = −0.05,
P = .617), and Digit Symbol Substitution Test (b = 0.01, P = .903) were not significantly
associated with FMD. When age was entered in the last step of our hierarchical regression,
we noted a significant relationship between measures of vascular health and Psychomotor
Speed performance after controlling for education, Framingham index, LDL, and HDL
cholesterols (IMT: b = −1.45, P = .002; FMD: b = 1.30, P = .006), which were attenuated
after controlling for the effects of age.
Executive Function—Hierarchical regression analysis of Executive Function revealed
that both age and education level were significantly associated with Executive Function
performance and this association was only modestly attenuated after controlling for
cerebrovascular risk factors and vascular health (Table 4). Cerebrovascular risk factors were
not associated with Executive Function when added to our model (F(4,114) = 1.32, P = .
267), and neither LDL-C (b = −0.29, P = .466), BMI (b = −0.45, P = .457), nor FSRP (b =
0.47, P = .162) were significant predictors, although higher levels of HDL-C tended to be
associated with poorer Executive Function (b = −0.83, P = .090). IMT was not a significant
predictor of Executive Function (F(1,98) = 0.50, b = −0.33, P = .481. Higher levels of FMD,
however, were associated with better Executive Function performance (F(1,94) = 3.94, b =
0.89, P = .050), and this relationship was only partially attenuated after IMT was entered
into the model again in the final step (F(1,87) = 2.69, b = 0.75, P = .105).
In exploratory analyses we found that the Trail Making Test B-A (b = −0.20, P = .041) was
strongly related to FMD, in addition to the Stroop Word and Stroop Color-Word tests, as
noted above. The Digit Span Test (b = 0.14, P = .189), Animal Naming (b = 0.01, P = .918),
COWAT (b = 0.10, P = .328), and Verbal Paired Associates (b = −0.11, P = .270), were not
significantly associated with FMD. When age was entered in the last step of our hierarchical
regression model, we noted a significant relationship between measures of vascular health
and Executive Function after controlling for education, Framingham index, LDL, and HDL
cholesterols (IMT: b = −0.85, P = .054; FMD: b = 1.32, P = .003), which were attenuated
after controlling for the effects of age.
Discussion
Results from the present analysis suggest that subclinical vascular dysfunction is associated
with poorer neurocognitive performance among overweight adults with high blood pressure.
Higher levels of FMD were associated with better executive functioning after controlling for
demographic factors and CVRF. In addition, greater levels of carotid artery IMT tended to
be related to poorer psychomotor speed.
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The present study provides support for our previous findings that lower levels of FMD and
higher levels of IMT are associated with poorer neurocognitive functioning after controlling
for background factors and CVRF {Smith, 2007 6698 /id}. Higher levels of IMT have been
shown to predict poorer neurocognitive functioning in numerous population-bases studies,
including the Rotterdam {Slooter, 1998 3131 /id} and Atherosclerosis Risk in Communities
studies {Cerhan, 1998 1441 /id}, among others {Komulainen, 2007 2030 /id}. IMT appears
to be most strongly associated with tests of psychomotor speed, processing efficiency, and
executive function {Auperin, 1996 2044 /id;Haley, 2007 2040 /id;Cohen, 2009 6699 /id},
although general measures of orientation {Kaplan, 1996 2045 /id} and memory {Muller,
2007 269 /id} also may be related to IMT. In addition, higher IMT has been associated with
both structural white matter changes {de Leeuw, 2000 2493 /id} and functional brain
changes during tasks of frontal-lobe functioning among patients with cardiovascular disease
{Haley, 2007 6700 /id}. The association between IMT and neurocognitive function in our
study was relatively weaker than that observed in previous studies {Komulainen, 2007
2030 /id;Hoth, 2007 20 /id} most likely due to differences in enrollment criteria; previous
studies have examined the association between IMT and neurocognition among older adults
with cardiovascular disease and higher levels of IMT, whereas our study was conducted
among relatively younger individuals and excluded those with a history of cardiovascular
events. In addition, our study sample included a substantial number of African-Americans
(41%) and women (64%) relative to previous studies, which may also have influenced the
pattern of our findings.
Relative to the substantial literature on IMT, endothelial dysfunction and neurocognitive
performance have been less well studied. We have previously reported that impaired
endothelial function is associated with poorer neurocognitive performance among middle-
aged adults with major depressive disorder and that the endothelial function and
neurocognition relationship appeared to mediate the observed relationships between CVRF,
IMT, and neurocognitive performance {Smith, 2007 6698 /id}. In addition, endothelial
dysfunction has been shown to differentiate individuals with Alzheimer’s disease (AD) from
healthy controls {Dede, 2007 3113 /id}, and a graded relationship has been observed
between the progression of AD pathology and FMD. Recent studies have also shown that
FMD from the brachial artery is associated with white matter disease burden {Hoth, 2007
20 /id}, particularly in periventricular brain regions {de Leeuw, 2002 2136 /id}. In the
present analysis we found that higher levels of FMD were associated with better executive
functioning, suggesting that better endothelial function is associated with improved
executive abilities. However, we did not observe an association between GTN-D, which
measures a more general vascular response, and neurocognitive performance, suggesting
that the relationship observed between FMD and executive functioning may be specific to
the vascular endothelium. These findings suggest that the association between vascular
health and neurocognitive performance may depend on endothelium-derived nitric oxide
release and not solely on vascular smooth muscle function.
Neurocognitive deficits are common among individuals with high blood pressure {Robbins,
2005 284 /id;Elias, 2003 37 /id}, which is associated with an increased risk of stroke and
AD {Birkenhager, 2001 2532 /id}. In addition, the deleterious effects of high blood pressure
on neurocognition appear to be particularly strong among individuals with central obesity
{Waldstein, 2006 6687 /id;Elias, 2003 37 /id}. Recent evidence suggests that among
middle-aged adults only those with both hypertension and obesity exhibit neurocognitive
dysfunction, while neither hypertension nor obesity are independent predictors {Wolf, 2007
6685 /id}. In the present study, our findings were unchanged when analyses were restricted
to those individuals with clinically-defined levels of hypertension (data not shown).
Although this study may be the first to examine the relationship between neurocognitive
functioning and vascular health among individuals with high blood pressure, elevated blood
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pressure is a well-known risk factor for increasing levels of IMT {Zanchetti, 1998 6735 /id}
and endothelial dysfunction {Taddei, 2000 90 /id} and both are associated with incident
cardiovascular events in this population {Gokce, 2003 9 /id;Lorenz, 2007 6697 /id;Lorenz,
2006 6736 /id}. In addition, high blood pressure has been shown to predict greater burden of
white matter disease {de Leeuw, 2002 2489 /id}, cerebral infarctions {Uehara, 1999 45 /id},
gray matter volume loss {Gianaros, 2006 6505 /id}, and poorer regional perfusion {Beason-
Held, 2007 6528 /id}.
The present study has several limitations. First, the ENCORE inclusion criteria precluded
older individuals with neurocognitive dysfunction from participating and it is therefore
unclear if the same pattern of findings would have been observed in a sample of older and
more cognitively disabled adults. Second, our neurocognitive test battery was designed
primarily to assess executive functions and the majority of measures had significant speed
requirements. It is therefore unclear to what extent endothelial dysfunction and vascular
health might be associated with memory or tasks of executive function without speed
components. Finally, because our study was cross-sectional we are unable to examine how
the present pattern of findings might change over extended follow-up periods.
In summary, higher levels of IMT and lower FMD were associated with poorer
neurocognitive function among overweight and obese adults with high blood pressure.
Notably, these relationships were observed above and beyond the influence of background
characteristics and CVRF. Future studies should examine the longitudinal relationship
between endothelial dysfunction and neurocognition among older adults to assess the role of
declining FMD in predicting neurocognitive decline. In addition, additional intervention
trials are needed to determine whether improving endothelial function and vascular health
might result in better neurocognitive performance.
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Table 1
Background characteristics of sample. Data are given as mean (SD) unless otherwise indicated. SBP indicates
systolic blood pressure; DBP indicates diastolic blood pressure; FSRP = Framingham Stroke Risk Profile;
IMT = intima medial thickness; mm Hg indicates millimeters of mercury; KGS indicates kilograms.
Variable Mean (SD) Range
Age, y 52.3 (9.6) 36 – 77
Males, n (%) 45 (36) N/A
Whites, n (%) 68 (59) N/A
Years of education 15.3 (2.6) 8 – 20
College Degree, n (%) 68 (55) N/A
IMT, mm 0.70 (0.14) 0.46 – 1.25
Non-Endothelial Dependent Arterial Diameter 17.3 (7.2) 3.7 – 40.6
Flow Mediated Dilation 2.6 (3.6) −3.8 – 17.4
Framingham Stroke Risk Profile 6.0 (2.8) 2 – 16
Current Smoker, n (%) 11 (8.9) N/A
Clinic SBP, mm Hg 138.3 (8.4) 122 – 162
Clinic DBP, mm Hg 86.1 (6.5) 69 – 100
Hypertensive*, n (%) 55 (44.4) N/A
High Density Lipoprotein 53.8 (14.4) 26 – 108
Low Density Lipoprotein 125.1 (35.6) 66 – 285
Weight, kgs 93.5 (14.3) 67 – 130
BMI, kgs / m2 32.8 (3.8) 25.6 – 39.9
Trail Making Test B-A, seconds 42.7 (33.2) −29 – 176
Stroop Word 96.8 (14.3) 49 – 134
Stroop Color 69.7 (12.6) 39 – 103
Stroop Color/Word 38.5 (9.9) 13–63
Verbal Paired Associates 17.2 (3.9) 5 – 24
COWAT 38.3 (11.2) 7 – 64
Animals 21.2 (5.4) 7 – 38
Ruff 2 & 7 Test 236.9 (50.2) 101 – 423
Digit Symbol Substitution Test 57.4 (10.9) 30 – 80
Digit Span 15.1 (3.6) 8 – 24
*
Hypertensive defined as either SBP > 140 or DBP > 90.
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Table 2
Neurocognitive factor analytic results. Results revealed two underlying factors, which we have labeled
Psychomotor Speed and Executive Function.
Test Psychomotor Speed Executive Function
Stroop Word 71 44
Stroop Color 83 38
Stroop Color-Word 67 54




Digit Span 29 67
Digit Symbol Substitution Test 76 13
Ruff 2 & 7 Test 71 10
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